Now showing items 1-20 of 31
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial | Crucitti, T.; Taylor, D.; Beelaert, G.; Fransen, K.; Van Damme, L. | Clinical and Vaccine Immunology | 2011 | Article |
| Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a Microbicide Phase III Clinical Trial | Crucitti, T.; Fransen, K.; Maharaj, R.; Tenywa, T.; Massinga Loembe, M.; Murugavel, K. G.; Mendonca, K.; Abdellati, S.; Beelaert, G.; Van Damme, L. | PLoS ONE | 2010 | Article-E |
| Challenges in HIV-prevention microbicide research | Harrison, P.; Mellors, J. W.; Richardson, B.; Masse, B. R.; Abdool Karim, Q.; Abdool Karim, S. S.; Cates, W.; Coletti, A. S.; Darbyshire, J.; Dorflinger, L. J.; Feldblum, P.; Gabelnick, H.; Halpern, V. G.; Hillier, S. L.; Jespers, V.; Kharsany, A. B. M.; McCormack, S.; Nunn, A.; McGowan, I.; Omar, R. F.; Padian, N. S.; Pedneault, L.; Robbiani, M. P.; Sailer, J.; Taylor, D.; Tolley, E. E.; Van Damme, L.; Vermund, S. H.; van de Wijgert, J. | Science | 2008 | Rapid Response-e |
| Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission | Van Damme, L.; Govinden, R.; Mirembe, F. M.; Guédou, F.; Solomon, S.; Becker, M. L.; Pradeep, B. S.; Krishnan, A. K.; Alary, M.; Pande, B.; Ramjee, G.; Deese, J.; Crucitti, T.; Taylor, D. | New England Journal of Medicine | 2008 | Article |
| Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission | Van Damme, L.; Govinden, R.; Mirembe, F. M.; Guédou, F.; Solomon, S.; Becker, M. L.; Pradeep, B. S.; Krishnan, A. K.; Alary, M.; Pande, B.; Ramjee, G.; Deese, J.; Crucitti, T.; Taylor, D. | New England Journal of Medicine | 2008 | Article |
| Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection | Crucitti, T.; Jespers, V.; Van Damme, L.; Van Dyck, E.; Buvé, A. | Diagnostic Microbiology and Infectious Disease | 2007 | Article |
| Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men | Jespers, V.; Buvé, A.; Van Damme, L. | Sexually Transmitted Diseases | 2007 | Article |
| A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteers | McCormack, S.; Jespers, V.; Low-Beer, N.; Gabe, R.; Kaganson, N.; Chapman, A.; Nunn, A.; Lacey, C.; Van Damme, L. | Sexually Transmitted Diseases | 2005 | Article |
| Need for a true placebo for vaginal microbicide efficacy trials [reply] | Van Damme, L.; Rees, H.; Ramjee, G.; Laga, M.; Mâsse, B. | Lancet | 2003 | Letter |
| Penile application of dextrin sulphate gel (Emmelle) | Van Damme, L.; Jespers, V.; Van Dyck, E.; Chapman, A. | Contraception | 2002 | Article |
| Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial | Van Damme, L.; Ramjee, G.; Alary, M.; Vuylsteke, B.; Chandeying, V.; Rees, H.; Sirivongrangson, P.; Mukenge-Tshibaka, L.; Ettiègne-Traoré, V.; Uaheowitchai, C.; Abdool Karim, S. S.; Mâsse, B.; Perriëns, J.; Laga, M. | Lancet | 2002 | Article |
| Recommendations for the clinical development of topical microbicides: an update | Mauck, C.; Rosenberg, Z.; Van Damme, L.; International Working Group on Microbicides, | AIDS | 2001 | Article |
| Evaluation of the Roche Neisseria gonorrhoeae 16S rRNA PCR for confirmation of AMPLICOR PCR-positive samples and comparison of its diagnostic performance according to storage conditions and preparation of endocervical specimens | Van Dyck, E.; Smet, H.; Van Damme, L.; Laga, M. | Journal of Clinical Microbiology | 2001 | Article |
| Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests | Van Dyck, E.; Ieven, M.; Pattyn, S.; Van Damme, L.; Laga, M. | Journal of Clinical Microbiology | 2001 | Article |
| A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women | Van Damme, L.; Wright, A.; Depraetere, K.; Rosenstein, I.; Vandersmissen, V.; Poulter, L.; McKinlay, M.; Van Dyck, E.; Weber, J.; Profy, A.; Laga, M.; Kitchen, V. | Sexually Transmitted Infections | 2000 | Article |
| Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers | Van Damme, L.; Chandeying, V.; Ramjee, G.; Rees, H.; Sirivongrangson, P.; Laga, M.; Perriëns, J. | AIDS | 2000 | Article |
| Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world | Ramjee, G.; Morar, N. S.; Alary, M.; Mukenge-Tshibaka, L.; Vuylsteke, B.; Ettiègne-Traoré, V.; Chandeying, V.; Karim, S. A.; Van Damme, L. | AIDS | 2000 | Article |
| Clinical research with topical microbicides as a potential HIV prevention method | Van Damme, L. | AIDS Reader | 2000 | Article |
| Pointer: ethical and technical aspects of microbicide effectiveness trials | Van Damme, L.; Laga, M. | International Antiviral News | 1999 | Article |
| Microbicides and barrier methods in HIV prevention | Van Damme, L.; Rosenberg, Z. F. | AIDS | 1999 | Article |
Now showing items 1-20 of 31